Should I buy or sell Elekta AB (publ) stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street analysts is that investors should "sell" EKTAY shares. View EKTAY analyst ratings or view top-rated stocks .

How have EKTAY shares performed in 2024?

Elekta AB (publ)'s stock was trading at $8.1495 at the beginning of 2024. Since then, EKTAY stock has decreased by 16.9% and is now trading at $6.7750. View the best growth stocks for 2024 here .

Are investors shorting Elekta AB (publ)?

Elekta AB (publ) saw a increase in short interest in March. As of March 31st, there was short interest totaling 2,400 shares, an increase of 71.4% from the March 15th total of 1,400 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is currently 0.3 days. View Elekta AB (publ)'s Short Interest .

How were Elekta AB (publ)'s earnings last quarter?

Elekta AB (publ) (OTCMKTS:EKTAY) issued its earnings results on Thursday, February, 29th. The company reported $0.08 EPS for the quarter. The firm had revenue of $426.51 million for the quarter. Elekta AB (publ) had a trailing twelve-month return on equity of 15.16% and a net margin of 7.88%.

How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?

Elekta AB (publ) announced a dividend on Tuesday, January 30th. Stockholders of record on Tuesday, February 27th will be given a dividend of $0.1146 per share on Monday, March 18th. The ex-dividend date is Monday, February 26th. Read our dividend analysis for EKTAY .

Is Elekta AB (publ) a good dividend stock?

Elekta AB (publ) (OTCMKTS:EKTAY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.31%. The dividend payout ratio is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EKTAY will have a dividend payout ratio of 34.04% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for EKTAY .

How do I buy shares of Elekta AB (publ)?

Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:EKTAY

Elekta AB (publ) (EKTAY) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)

Free EKTAY Stock Alerts

$6.78

-0.09 (-1.31%)

(As of 04/18/2024 ET)

Compare

Today's Range: $6.76
▼
$6.81
50-Day Range: $6.78
▼
$7.82
52-Week Range: $6.52
▼
$8.65

Volume: 24,304 shs
Average Volume: 10,405 shs
Market Capitalization: $2.60 billion

P/E Ratio: 18.82
Dividend Yield: 2.36%
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Dividend Earnings Financials Headlines Short Interest

Get Elekta AB (publ) alerts:

Elekta AB (publ) MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.00% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 14.63%
From $0.41 to $0.47 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.17 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Elekta AB (publ).

3.0

Short Interest

Percentage of Shares Shorted
0.00% of the outstanding shares of Elekta AB (publ) have been sold short.
Short Interest Ratio / Days to Cover
Elekta AB (publ) has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Elekta AB (publ) has recently increased by 71.43%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Yield
Elekta AB (publ) pays a meaningful dividend of 2.31%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Elekta AB (publ) does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Elekta AB (publ) is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Elekta AB (publ) will have a dividend payout ratio of 34.04% next year. This indicates that Elekta AB (publ) will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for EKTAY.

3.0

News and Social Media Coverage

News Sentiment
Elekta AB (publ) has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Medical companies.
MarketBeat Follows
1 people have added Elekta AB (publ) to their MarketBeat watchlist in the last 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Elekta AB (publ) insiders have not sold or bought any company stock.
Percentage Held by Insiders
41.28% of the stock of Elekta AB (publ) is held by insiders. A high percentage of insider ownership can be a sign of company health.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Elekta AB (publ) are expected to grow by 14.63% in the coming year, from $0.41 to $0.47 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Elekta AB (publ) is 18.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.62.
Price to Earnings Ratio vs. Sector
The P/E ratio of Elekta AB (publ) is 18.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 198.00.
Price to Book Value per Share Ratio
Elekta AB (publ) has a P/B Ratio of 2.79. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Did you know you can now trade Bitcoin in your regular brokerage account?

You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!

>> Tap here to sign up and join them for the imminent workshop

About Elekta AB (publ) Stock (OTCMKTS:EKTAY)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

EKTAY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EKTAY Stock News Headlines

March 1, 2024 | gurufocus.com

Q3 2024 Elekta AB (publ) Earnings Call Transcript

February 23, 2024 | msn.com

Elekta AB (publ) goes ex dividend Monday

April 19, 2024 | Darwin (Ad)

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

February 20, 2024 | finance.yahoo.com

Is Elekta (EKTAY) Stock Undervalued Right Now?

December 17, 2023 | msn.com

Elekta AB - ADR (EKTAY) Price Target Increased by 5.21% to 8.43

December 7, 2023 | finance.yahoo.com

Is Elekta (EKTAY) a Great Value Stock Right Now?

November 27, 2023 | msn.com

Elekta AB - ADR (EKTAY) Price Target Increased by 6.97% to 8.01

November 9, 2023 | morningstar.com

Elekta AB ADR EKTAY

April 19, 2024 | Darwin (Ad)

Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report

November 8, 2023 | msn.com

Elekta gets $40m radiation tech contract from India’s KIMS

October 23, 2023 | stockhouse.com

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

August 26, 2023 | seekingalpha.com

Elekta AB (publ) 2024 Q1 - Results - Earnings Call Presentation

August 26, 2023 | seekingalpha.com

Elekta AB (publ) (EKTAF) Q1 2024 Earnings Call Transcript

July 19, 2023 | wsj.com

Elekta AB Series B

April 30, 2023 | seekingalpha.com

Epiroc AB (publ) 2023 Q1 - Results - Earnings Call Presentation

November 24, 2022 | finance.yahoo.com

European shares struggle for direction as traders weigh rate outlook

November 5, 2022 | finance.yahoo.com

Elekta AB (publ) (EKTAY)

October 13, 2022 | finance.yahoo.com

Elekta AB (publ) (EKTA-B.ST)

October 9, 2022 | fool.com

ELEKTA B SHS ADR (OTC: EKTAY)

October 2, 2022 | reuters.com

Elekta AB (publ)

August 27, 2022 | seekingalpha.com

Elekta AB (publ) 2023 Q1 - Results - Earnings Call Presentation

August 25, 2022 | seekingalpha.com

Elekta AB (publ) (EKTAF) Q1 2023 Earnings Call Transcript

August 25, 2022 | finance.yahoo.com

Edited Transcript of EKTAb.ST earnings conference call or presentation 25-Aug-22 8:00am GMT

May 15, 2022 | seekingalpha.com

Elekta (EKTAY) Presents at ESTRO 2022

February 24, 2022 | finance.yahoo.com

Elekta: Interim report, May-January 2021/22

January 7, 2022 | seekingalpha.com

New finance chief at Elekta

January 7, 2022 | finance.yahoo.com

Elekta to appoint Tobias Hägglöv as Chief Financial Officer

See More Headlines

Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/18 Dividend: 2/26/2024
Last Earnings: 2/29/2024
Dividend Payable: 3/18/2024
Today: 4/19/2024
Fiscal Year End: 4/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical laboratories
Sub-Industry: N/A
Current Symbol: OTCMKTS:EKTAY
CUSIP: N/A
CIK: 1451160
Web: www.elekta.com
Phone: (685) 872-5400
Fax: 46-8-587-255-00
Employees: 4,540
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.36
Trailing P/E Ratio: 18.82
Forward P/E Ratio: 16.52
P/E Growth: N/A
Net Income: $90.25 million
Net Margins: 7.88%
Pretax Margin: 8.25%
Return on Equity: 15.16%
Return on Assets: 5.01%

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 1.12
Quick Ratio: 0.83

Sales & Book Value

Annual Sales: $1.61 billion
Price / Sales: 1.61
Cash Flow: $0.55 per share
Price / Cash Flow: 12.24
Book Value: $2.43 per share
Price / Book: 2.79

Miscellaneous

Outstanding Shares: 383,570,000
Free Float: 225,231,000
Market Cap: $2.60 billion
Optionable: Not Optionable
Beta: 1.16

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Laurent Leksell (Age 72)
Founder & Chairman
Comp: $1.64M
Mr. Gustaf Salford (Age 47)
President & CEO
Comp: $14.62M
Mr. Tobias Hagglov (Age 46)
Chief Financial Officer
Mr. Peter Nyquist (Age 59)
Head of Investor Relations
Mr. Jonas Bolander (Age 58)
Executive VP of Group Functions, Secretary & General Counsel
Mr. Mattias Thorsson
VP and Head of Corporate Communications & Public Affairs
Ms. Anna Conneryd Lundgren (Age 39)
Executive VP & Chief People Officer
Mr. John Lapré (Age 60)
President of Brachy & Neuro Solutions
Mr. Maurits Wolleswinkel (Age 53)
President of Linac & Software Solutions
Mr. Habib Nehme (Age 60)
Chief Commercial Officer

Key Competitors

View All Competitors

EKTAY Stock Analysis - Frequently Asked Questions

Should I buy or sell Elekta AB (publ) stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street analysts is that investors should "sell" EKTAY shares.
View EKTAY analyst ratings or view top-rated stocks.
How have EKTAY shares performed in 2024?: Elekta AB (publ)'s stock was trading at $8.1495 at the beginning of 2024. Since then, EKTAY stock has decreased by 16.9% and is now trading at $6.7750.
View the best growth stocks for 2024 here.
Are investors shorting Elekta AB (publ)?: Elekta AB (publ) saw a increase in short interest in March. As of March 31st, there was short interest totaling 2,400 shares, an increase of 71.4% from the March 15th total of 1,400 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is currently 0.3 days.
View Elekta AB (publ)'s Short Interest.
How were Elekta AB (publ)'s earnings last quarter?: Elekta AB (publ) (OTCMKTS:EKTAY) issued its earnings results on Thursday, February, 29th. The company reported $0.08 EPS for the quarter. The firm had revenue of $426.51 million for the quarter. Elekta AB (publ) had a trailing twelve-month return on equity of 15.16% and a net margin of 7.88%.

How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?: Elekta AB (publ) announced a dividend on Tuesday, January 30th. Stockholders of record on Tuesday, February 27th will be given a dividend of $0.1146 per share on Monday, March 18th. The ex-dividend date is Monday, February 26th.
Read our dividend analysis for EKTAY.
Is Elekta AB (publ) a good dividend stock?: Elekta AB (publ) (OTCMKTS:EKTAY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.31%. The dividend payout ratio is 44.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EKTAY will have a dividend payout ratio of 34.04% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EKTAY.
How do I buy shares of Elekta AB (publ)?: Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EKTAY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial